Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
4403 On Other Exchanges
Symbol
Exchange
4403 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

nof corp (4403) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NOF CORP (4403)

Related News

No related news articles were found.

nof corp (4403) Related Businessweek News

No Related Businessweek News Found

nof corp (4403) Details

NOF Corporation is engaged in oleo and specialty chemicals business worldwide. The company operates in four segments: Functional Chemicals, Life Science, Explosive & Propulsion, and Others. It offers fatty acids and glycerin, fatty acid derivatives, and surfactants, as well as petrochemical products; and functional chemicals and polymers, such as organic peroxides, petrochemicals, and functional polymers. The company also provides industrial explosives comprising tunnel construction supplying dynamites, emulsion explosives, electric detonator caps, remote control blasting systems, and other products; explosives for defense and space use; and consumer products, including automotive safety components, temperature indicating materials, sterilization materials, pharmaceutical materials, and crime prevention devices. In addition, it offers edible oils, such as margarine, shortening, confectionary oils, depanning oils, fillings and toppings, oil and fat powders, and ingredients for processed foods; and health-related products that comprise functional lipids, nano-emulsion products, micro-encapsulated products, and enteral nutritional products. Further, the company develops life science products, such as MPC biocompatible materials; and diagnostic and research-use reagents comprising antibodies for various antigens, as well as produces activated PEGs and PEGlyation, phospholipids, and unsaturated fatty acids and their derivatives. Additionally, it provides functional films, including anti-reflection film ReaLook, anti-finger mark film ClearTouch and PenFit, and matching film LightNavi for the use in tablets and Smartphones. The company also supplies anti-corrosion treatment systems; dry galvanizing treatment products; and sealers. In addition, it is involved in truck transportation, freight handling, insurance, and real estate businesses. The company was founded in 1937 and is headquartered in Tokyo, Japan.

3,857 Employees
Last Reported Date: 06/27/14
Founded in 1937

nof corp (4403) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nof corp (4403) Key Developments

NOF Corporation to Report Q3, 2015 Results on Feb 04, 2015

NOF Corporation announced that they will report Q3, 2015 results on Feb 04, 2015

NOF Corporation Announces New Product Polysorbate 20(GS)TM

NOF Corporation announced new product Polysorbate 20(GS)TM. Polysorbate 20(GS)TM is multi-compendial (NF, EP and JPE) and can be applied to various drugs as a multi-purpose surfactant, e.g., as a solubilizing agent for poorly hydrophilic drugs, as a stabilizing agent for injectable preparations for biologics such as vaccines, antibodies, cytocines and so on. It is available from 1kg amber glass bottles(GMP) and 10kg stainless drums (GMP).

NOF Corporation to Report Q2, 2015 Results on Nov 05, 2014

NOF Corporation announced that they will report Q2, 2015 results on Nov 05, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4403:JP ¥929.00 JPY +2.00

4403 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abzena PLC 84.50 GBp 0.00
Dr Reddy's Laboratories Ltd 3,388 INR +1.95
Enzon Pharmaceuticals Inc $1.50 USD -0.22
Nektar Therapeutics $10.56 USD -0.21
Novo Nordisk A/S kr394.00 DKK +3.70
View Industry Companies
 

Industry Analysis

4403

Industry Average

Valuation 4403 Industry Range
Price/Earnings 16.1x
Price/Sales 1.0x
Price/Book 1.4x
Price/Cash Flow 16.1x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOF CORP, please visit www.nof.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.